title: Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.
authors.forename: A
authors.initials: A
authors.lastname: Räkel
authors.forename: G
authors.initials: G
authors.lastname: Renier
authors.forename: A
authors.initials: A
authors.lastname: Roussin
authors.forename: J
authors.initials: J
authors.lastname: Buithieu
authors.forename: J-C
authors.initials: JC
authors.lastname: Mamputu
authors.forename: O
authors.initials: O
authors.lastname: Serri
mesh_terms: D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004311:Double-Blind Method; D004730:Endothelium, Vascular / Q000187:drug effects; D005260:Female; D005907:Gliclazide / Q000627:therapeutic use*; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D007004:Hypoglycemic Agents; D005907:Gliclazide; D005905:Glyburide